I agree with those who would like to see more guidance for the future in the report, but hopefully it will come in other ways. An updated corporate presentation could really answer most of our questions, but news is what's really needed to move the share price. Trial news is certainly welcome, it shows progression and provides hope for the future. The bigger news IMHO will deal with new partnerships or other forms of collaborations.

I don't know what the rights to market our products in California will be, but in that California represents the 6th largest economy in the world, I would think they should be considerable. Of course I don't know that California will be singled out, or if companies are coming forward who truly can get products into all State's where they are legal. Regardless of how it's done, I believe that such agreements will bring in tens to hundreds of millions over the not to distant future, and that could build into billions as product sales are initiated and grow for a few years. They should grow dramatically faster when the products are actually approved as drugs and subject to coverage under insurance.

Companies never discuss partnerships before they're consummated except in the broadest terms about having ongoing discussions without ever revealing with who. I believe that OWCP has alluded to this in the past, most recently at the Wall St. Conference.

Gary